|
|
|
|
Hemcheck's Newsletter - September 2022
|
|
|
In September, we continued on the path we have laid out with focus on our commercial activities. We are progressing with new orders and fruitful discussions with customers and distributors. It's also positive that we now, and our partners, can attend many more industry fairs and customer meetings in-person, compared to during the pandemic restrictions when most of them were canceled. We hope these efforts will be rewarding in the coming weeks and months ahead.
One important step for a medical technology company is to certify its quality management system against ISO 13485. We have earlier waited with going through this process due to other priorities - We are now on track to be certified.
|
|
|
|
|
This will make some international sales and market entries easier and we hope to have the certificate in place before the end of the year!
|
|
In this newsletter you can read more about some of our conducted commercial activities and the ISO certification process.
|
|
|
|
Hemcheck receives follow up order from its Greek distributor
|
|
Hemcheck has received a first follow-up order from its Greek distributor Antisel. The order shows that Antisel is active in the market and that Greek customers are in demand of Hemcheck’s products.
|
|
|
|
|
Hemcheck receives order from Czech distributor intended for university hospital in Prague
|
Hemcheck has also received an order from Promedica, a Czech distributor. The order concerns bgs-Test for diagnostic use and the end customer is the General University Hospital in Prague.
|
|
|
|
|
|
The ongoing ISO-certification process from a Production perspective
|
|
|
“The process of certifying the company according to ISO 13485 has reached its final stage during September, as Hemcheck has completed step 2, the certification audit. The outcome was positive with a recommendation to certify the company according to ISO 13485. Hemcheck expects to receive the certificate in 7-9 weeks”
|
Production & Logistics Manager
|
|
|
|
|
|
|
|
|
|
|
|
|
|
